Skip to main content

Endogene Cannabinoide und das Endocannabinoidsystem

  • Living reference work entry
  • First Online:
Handbuch Psychoaktive Substanzen

Part of the book series: Springer Reference Psychologie ((SRP))

Zusammenfassung

Das Endocannabinoidsystem mit seinen endogenen Cannabinoiden, Cannabinoid- und anderen Rezeptoren sowie Proteinen, die für die Biosynthese und den Abbau von Endocannabinoiden wie Anandamid (N-Arachidonoylethanolamid) und 2-AG (2-Arachidonoylglycerol) verantwortlich sind, übt im zentralen Nervensystem und in vielen anderen Organen wichtige biologische Funktionen aus. Heute sind etwa 200 endocannabinoidähnliche Substanzen bekannt. Störungen der normalen Funktionsweise dieses Neurotransmittersystems können zu Beeinträchtigungen von Organfunktionen führen, wie beispielsweise Störungen der Hirnleistungsfähigkeit, von Fortpflanzungs-, Immun- und Magendarmfunktionen. Seine Hauptfunktion besteht in der Hemmung der Freisetzung anderer Neurotransmitter. Bei Erkrankungen kann eine spezifische Beeinflussung des Endocannabinoidsystems, beispielsweise durch eine Hemmung des Abbaus von Endocannabinoiden oder die Zufuhr pflanzlicher Cannabinoide, die an Cannabinoidrezeptoren binden oder die Konzentration von Endocannabinoiden beeinflussen, von Nutzen sein.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Institutional subscriptions

Similar content being viewed by others

Literatur

  • Baker, D., Pryce, G., Giovannoni, G., & Thompson, A. J. (2003). The therapeutic potential of cannabis. Lancet Neurology, 2(5), 291–298.

    Article  PubMed  Google Scholar 

  • Belmonte, S. L., & Blaxall, B. C. (2011). G protein coupled receptor kinases as therapeutic targets in cardiovascular disease. Circulation Research, 109(3), 309–319.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bilkei-Gorzo, A., Racz, I., Valverde, O., Otto, M., Michel, K., Sastre, M., et al. (2005). Early age-related cognitive impairment in mice lacking cannabinoid CB1 receptors. Proceedings of the National Academy of Sciences of the United States of America, 102(43), 15670–15675.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bíró, T., Tóth, B. I., Haskó, G., Paus, R., & Pacher, P. (2009). The endocannabinoid system of the skin in health and disease: Novel perspectives and therapeutic opportunities. Trends in Pharmacological Sciences, 30(8), 411–420.

    Article  PubMed  PubMed Central  Google Scholar 

  • Bradshaw, H. B., Rimmerman, N., Hu, S. S., Burstein, S., & Walker, J. M. (2009). Novel endogenous N-acyl glycines identification and characterization. Vitamins and Hormones, 81, 191–205.

    Article  PubMed  Google Scholar 

  • Cencioni, M. T., Chiurchiù, V., Catanzaro, G., Borsellino, G., Bernardi, G., Battistini, L., et al. (2010). Anandamide suppresses proliferation and cytokine release from primary human T-lymphocytes mainly via CB2 receptors. Public Library of Science One, 5(1), e8688.

    PubMed  PubMed Central  Google Scholar 

  • Cohen-Yeshurun, A., Willner, D., Trembovler, V., Alexandrovich, A., Mechoulam, R., Shohami, E., et al. (2013). N-arachidonoyl-L-serine (AraS) possesses proneurogenic properties in vitro and in vivo after traumatic brain injury. Journal of Cerebral Blood Flow and Metabolism, 33(8), 1242–1250.

    Article  PubMed  PubMed Central  Google Scholar 

  • de Kloet, A. D., & Woods, S. C. (2009). Minireview: Endocannabinoids and their receptors as targets for obesity therapy. Endocrinology, 150(6), 2531–2536.

    Article  PubMed  Google Scholar 

  • Devane, W. A., Dysarz, F. A., 3rd, Johnson, M. R., Melvin, L. S., & Howlett, A. C. (1988). Determination and characterization of a cannabinoid receptor in rat brain. Molecular Pharmacology, 34(5), 605–613.

    PubMed  Google Scholar 

  • Devane, W. A., Hanus, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science, 258(5090), 1946–1949.

    Article  PubMed  Google Scholar 

  • Elphick, M. R. (2012). The evolution and comparative neurobiology of endocannabinoid signalling. Philosophical Transactions of the Royal Society, B: Biological Sciences, 367(1607), 3201–3215.

    Article  PubMed Central  Google Scholar 

  • Fu, J., Bottegoni, G., Sasso, O., Bertorelli, R., Rocchia, W., Masetti, M., et al. (2011). A catalytically silent FAAH-1 variant drives anandamide transport in neurons. Nature Neurosciene, 15(1), 64–69.

    Article  Google Scholar 

  • Hanus, L., Abu-Lafi, S., Fride, E., Breuer, A., Vogel, Z., Shalev, D. E., et al. (2001). 2-arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proceedings of the National Academy of Sciences of the United States of America, 98(7), 3662–3665.

    Article  PubMed  PubMed Central  Google Scholar 

  • Hu, S. S., & Mackie, K. (2015). Distribution of the endocannabinoid system in the central nervous system. Handbook of Experimental Pharmacology, 231, 59–93.

    Article  PubMed  Google Scholar 

  • Louvet, A., Teixeira-Clerc, F., Chobert, M. N., Deveaux, V., Pavoine, C., Zimmer, A., et al. (2011). Cannabinoid CB2 receptors protect against alcoholic liver disease by regulating Kupffer cell polarization in mice. Hepatology, 54(4), 1217–1226.

    Article  PubMed  Google Scholar 

  • Maccarrone, M., Bab, I., Bíró, T., Cabral, G. A., Dey, S. K., Di Marzo, V., et al. (2015). Endocannabinoid signaling at the periphery: 50 years after THC. Trends in Pharmacological Sciences, 36(5), 277–296.

    Article  PubMed  PubMed Central  Google Scholar 

  • Marinelli, S., Di Marzo, V., Florenzano, F., Fezza, F., Viscomi, M. T., van der Stelt, M., et al. (2007). N-arachidonoyl-dopamine tunes synaptic transmission onto dopaminergic neurons by activating both cannabinoid and vanilloid receptors. Neuropsychopharmacology, 32(2), 298–308.

    Article  PubMed  Google Scholar 

  • Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature, 346(6284), 561–564.

    Article  PubMed  Google Scholar 

  • Mechoulam, R., Ben-Shabat, S., Hanus, L., Ligumsky, M., Kaminski, N. E., Schatz, A. R., et al. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochemical Pharmacology, 50(1), 83–90.

    Article  PubMed  Google Scholar 

  • Mechoulam, R., & Parker, L. A. (2013). The endocannabinoid system and the brain. Annual Review of Psychology, 64, 21–47.

    Article  PubMed  Google Scholar 

  • Munro, S., Thomas, K. L., & Abu-Shaar, M. (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature, 365(6441), 61–65.

    Article  PubMed  Google Scholar 

  • Naccarato, M., Pizzuti, D., Petrosino, S., Simonetto, M., Ferigo, L., Grandi, F. C., et al. (2010). Possible Anandamide and Palmitoylethanolamide involvement in human stroke. Lipids in Health and Disease, 9, 47.

    Article  PubMed  PubMed Central  Google Scholar 

  • Ofek, O., Karsak, M., Leclerc, N., Fogel, M., Frenkel, B., Wright, K., et al. (2006). Peripheral cannabinoid receptor, CB2, regulates bone mass. Proceedings of the National Academy of Sciences of the United States of America, 103(3), 696–701.

    Article  PubMed  PubMed Central  Google Scholar 

  • Onaivi, E. S., Ishiguro, H., Gong, J. P., Patel, S., Meozzi, P. A., Myers, L., et al. (2008). Functional expression of brain neuronal CB2 cannabinoid receptors are involved in the effects of drugs of abuse and in depression. Annals of the New York Academy of Sciences, 1139, 434–449.

    Article  PubMed  PubMed Central  Google Scholar 

  • O’Sullivan, S. E. (2015). Endocannabinoids and the cardiovascular system in health and disease. Handbook of Experimental Pharmacology, 231, 393–422.

    Article  PubMed  Google Scholar 

  • Porter, A. C., Sauer, J. M., Knierman, M. D., Becker, G. W., Berna, M. J., Bao, J., et al. (2002). Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. Journal of Pharmacology and Experimental Therapeutics, 301(3), 1020–1024.

    Article  PubMed  Google Scholar 

  • Smoum, R., Bar, A., Tan, B., Milman, G., Attar-Namdar, M., Ofek, O., et al. (2010). Oleoyl serine, an endogenous N-acyl amide, modulates bone remodeling and mass. Proceedings of the National Academy of Sciences of the United States of America, 107(41), 17710–17715.

    Article  PubMed  PubMed Central  Google Scholar 

  • Sykaras, A. G., Demenis, C., Case, R. M., McLaughlin, J. T., & Smith, C. P. (2012). Duodenal enteroendocrine I-cells contain mRNA transcripts encoding key endocannabinoid and fatty acid receptors. Public Library of Science One, 7(8), e42373.

    PubMed  PubMed Central  Google Scholar 

  • Terrazzino, S., Berto, F., Dalle Carbonare, M., Fabris, M., Guiotto, A., Bernardini, D., et al. (2004). Stearoylethanolamide exerts anorexic effects in mice via down-regulation of liver stearoyl-coenzyme A desaturase-1 mRNA expression. Federation of American Societies for Experimental Biology Journal, 18(13), 1580–1582.

    PubMed  Google Scholar 

  • Wright, K. L., Duncan, M., & Sharkey, K. A. (2008). Cannabinoid CB2 receptors in the gastrointestinal tract: a regulatory system in states of inflammation. British Journal of Pharmacology, 153(2), 263–270.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Franjo Grotenhermen .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer-Verlag GmbH Deutschland

About this entry

Cite this entry

Grotenhermen, F. (2016). Endogene Cannabinoide und das Endocannabinoidsystem. In: von Heyden, M., Jungaberle, H., Majić, T. (eds) Handbuch Psychoaktive Substanzen. Springer Reference Psychologie . Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-55214-4_39-1

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-55214-4_39-1

  • Received:

  • Accepted:

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-55214-4

  • Online ISBN: 978-3-642-55214-4

  • eBook Packages: Springer Referenz Psychologie

Publish with us

Policies and ethics